Real-time PCR, Digital PCR, And End-point PCR Market Size, Share & Trends Analysis Report By Technology (Quantitative, Digital, End-point), By Product, By Application, By Region, And Segment Forecasts, 2024 - 2030
- Report ID: GVR-1-68038-552-6
- Number of Pages: 120
- Format: Electronic (PDF)
- Historical Range: 2018 - 2022
- Industry: Healthcare
Market Segmentation
- Global Real time PCR, digital PCR, and end-point PCR Technology Outlook (Revenue, USD Million, 2018 - 2030)
- Quantitative
- Consumables & Reagents
- Instruments
- Software & Services
- Digital
- Consumables & Reagents
- Instruments
- Software & Services
- End-point
- Consumables & Reagents
- Instruments
- Software & Services
- Quantitative
- Global Real time PCR, digital PCR, and end-point PCR Application Type Outlook (Revenue, USD Million, 2018 - 2030)
- Clinical
- Pathogen Testing
- Oncology testing
- Blood Screening
- Liquid Biopsy
- dPCR-based Non-Invasive Prenatal Testing (NIPT)
- Others
- Research
- Stem Cell Research
- DNA Cloning & Sequencing
- Recombinant DNA Technology
- Rare Mutation Detection
- Gene Expression
- Single Cell Analysis
- Microbiome Analysis
- Copy Number Variation Analysis
- Library Quantification (NGS)
- Characterization of Low-fold Changes in mRNA and miRNA
- Expression"
- Species Identification
- GMO Detection
- Others
- Forensic
- Clinical
- Global Real time PCR, digital PCR, and end-point PCR Product Outlook (Revenue, USD Million, 2018 - 2030)
- Consumables & Reagents
- Instruments
- Software & Services
- Global Real time PCR, digital PCR, and end-point PCR Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- North America Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Quantitative
- Consumables & Reagents
- Instruments
- Software & Services
- Digital
- Consumables & Reagents
- Instruments
- Software & Services
- End-point
- Consumables & Reagents
- Instruments
- Software & Services
- Quantitative
- North America Real time PCR, digital PCR, and end-point PCRMarket, By Application, 2018 - 2030 (USD Million)
- Clinical
- Pathogen Testing
- Oncology testing
- Blood Screening
- Liquid Biopsy
- dPCR-based Non-Invasive Prenatal Testing (NIPT)
- Others
- Research
- Stem Cell Research
- DNA Cloning & Sequencing
- Recombinant DNA Technology
- Rare Mutation Detection
- Gene Expression
- Single Cell Analysis
- Microbiome Analysis
- Copy Number Variation Analysis
- Library Quantification (NGS)
- Characterization of Low-fold Changes in mRNA and miRNA
- Expression"
- Species Identification
- GMO Detection
- Others
- Forensic
- Clinical
- North America Real time PCR, digital PCR, and end-point PCRMarket, by Product 2018 - 2030 (USD Million)
- Consumables & Reagents
- Instruments
- Software & Services
- U.S.
- U.S. Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Quantitative
- Consumables & Reagents
- Instruments
- Software & Services
- Digital
- Consumables & Reagents
- Instruments
- Software & Services
- End-point
- Consumables & Reagents
- Instruments
- Software & Services
- Quantitative
- U.S. Real time PCR, digital PCR, and end-point PCRMarket, By Application, 2018 - 2030 (USD Million)
- Clinical
- Pathogen Testing
- Oncology testing
- Blood Screening
- Liquid Biopsy
- dPCR-based Non-Invasive Prenatal Testing (NIPT)
- Others
- Research
- Stem Cell Research
- DNA Cloning & Sequencing
- Recombinant DNA Technology
- Rare Mutation Detection
- Gene Expression
- Single Cell Analysis
- Microbiome Analysis
- Copy Number Variation Analysis
- Library Quantification (NGS)
- Characterization of Low-fold Changes in mRNA and miRNA
- Expression"
- Species Identification
- GMO Detection
- Others
- Forensic
- Clinical
- U.S. Real time PCR, digital PCR, and end-point PCRMarket, by Product 2018 - 2030 (USD Million)
- Consumables & Reagents
- Instruments
- Software & Services
- U.S. Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Canada
- Canada Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Quantitative
- Consumables & Reagents
- Instruments
- Software & Services
- Digital
- Consumables & Reagents
- Instruments
- Software & Services
- End-point
- Consumables & Reagents
- Instruments
- Software & Services
- Quantitative
- Canada Real time PCR, digital PCR, and end-point PCRMarket, By Application, 2018 - 2030 (USD Million)
- Clinical
- Pathogen Testing
- Oncology testing
- Blood Screening
- Liquid Biopsy
- dPCR-based Non-Invasive Prenatal Testing (NIPT)
- Others
- Research
- Stem Cell Research
- DNA Cloning & Sequencing
- Recombinant DNA Technology
- Rare Mutation Detection
- Gene Expression
- Single Cell Analysis
- Microbiome Analysis
- Copy Number Variation Analysis
- Library Quantification (NGS)
- Characterization of Low-fold Changes in mRNA and miRNA
- Expression"
- Species Identification
- GMO Detection
- Others
- Forensic
- Clinical
- Canada Real time PCR, digital PCR, and end-point PCRMarket, by Product 2018 - 2030 (USD Million)
- Consumables & Reagents
- Instruments
- Software & Services
- Canada Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- North America Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Europe
- Europe Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Quantitative
- Consumables & Reagents
- Instruments
- Software & Services
- Digital
- Consumables & Reagents
- Instruments
- Software & Services
- End-point
- Consumables & Reagents
- Instruments
- Software & Services
- Quantitative
- Europe Real time PCR, digital PCR, and end-point PCRMarket, By Application, 2018 - 2030 (USD Million)
- Clinical
- Pathogen Testing
- Oncology testing
- Blood Screening
- Liquid Biopsy
- dPCR-based Non-Invasive Prenatal Testing (NIPT)
- Others
- Research
- Stem Cell Research
- DNA Cloning & Sequencing
- Recombinant DNA Technology
- Rare Mutation Detection
- Gene Expression
- Single Cell Analysis
- Microbiome Analysis
- Copy Number Variation Analysis
- Library Quantification (NGS)
- Characterization of Low-fold Changes in mRNA and miRNA
- Expression"
- Species Identification
- GMO Detection
- Others
- Forensic
- Europe Real time PCR, digital PCR, and end-point PCRMarket, by Product 2018 - 2030 (USD Million)
- Consumables & Reagents
- Instruments
- Software & Services
- UK
- UK Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Quantitative
- Consumables & Reagents
- Instruments
- Software & Services
- Digital
- Consumables & Reagents
- Instruments
- Software & Services
- End-point
- Consumables & Reagents
- Instruments
- Software & Services
- Quantitative
- UK Real time PCR, digital PCR, and end-point PCRMarket, By Application, 2018 - 2030 (USD Million)
- Clinical
- Pathogen Testing
- Oncology testing
- Blood Screening
- Liquid Biopsy
- dPCR-based Non-Invasive Prenatal Testing (NIPT)
- Others
- Research
- Stem Cell Research
- DNA Cloning & Sequencing
- Recombinant DNA Technology
- Rare Mutation Detection
- Gene Expression
- Single Cell Analysis
- Microbiome Analysis
- Copy Number Variation Analysis
- Library Quantification (NGS)
- Characterization of Low-fold Changes in mRNA and miRNA
- Expression"
- Species Identification
- GMO Detection
- Others
- Forensic
- Clinical
- UK Real time PCR, digital PCR, and end-point PCRMarket, by Product 2018 - 2030 (USD Million)
- Consumables & Reagents
- Instruments
- Software & Services
- UK Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Germany
- Germany Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Quantitative
- Consumables & Reagents
- Instruments
- Software & Services
- Digital
- Consumables & Reagents
- Instruments
- Software & Services
- End-point
- Consumables & Reagents
- Instruments
- Software & Services
- Quantitative
- Germany Real time PCR, digital PCR, and end-point PCRMarket, By Application, 2018 - 2030 (USD Million)
- Clinical
- Pathogen Testing
- Oncology testing
- Blood Screening
- Liquid Biopsy
- dPCR-based Non-Invasive Prenatal Testing (NIPT)
- Others
- Research
- Stem Cell Research
- DNA Cloning & Sequencing
- Recombinant DNA Technology
- Rare Mutation Detection
- Gene Expression
- Single Cell Analysis
- Microbiome Analysis
- Copy Number Variation Analysis
- Library Quantification (NGS)
- Characterization of Low-fold Changes in mRNA and miRNA
- Expression"
- Species Identification
- GMO Detection
- Others
- Forensic
- Clinical
- Germany Real time PCR, digital PCR, and end-point PCRMarket, by Product 2018 - 2030 (USD Million)
- Consumables & Reagents
- Instruments
- Software & Services
- Germany Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- France
- France Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Quantitative
- Consumables & Reagents
- Instruments
- Software & Services
- Digital
- Consumables & Reagents
- Instruments
- Software & Services
- End-point
- Consumables & Reagents
- Instruments
- Software & Services
- Quantitative
- France Real time PCR, digital PCR, and end-point PCRMarket, By Application, 2018 - 2030 (USD Million)
- Clinical
- Pathogen Testing
- Oncology testing
- Blood Screening
- Liquid Biopsy
- dPCR-based Non-Invasive Prenatal Testing (NIPT)
- Others
- Research
- Stem Cell Research
- DNA Cloning & Sequencing
- Recombinant DNA Technology
- Rare Mutation Detection
- Gene Expression
- Single Cell Analysis
- Microbiome Analysis
- Copy Number Variation Analysis
- Library Quantification (NGS)
- Characterization of Low-fold Changes in mRNA and miRNA
- Expression"
- Species Identification
- GMO Detection
- Others
- Forensic
- Clinical
- France Real time PCR, digital PCR, and end-point PCRMarket, by Product 2018 - 2030 (USD Million)
- Consumables & Reagents
- Instruments
- Software & Services
- France Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Italy
- Italy Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Quantitative
- Consumables & Reagents
- Instruments
- Software & Services
- Digital
- Consumables & Reagents
- Instruments
- Software & Services
- End-point
- Consumables & Reagents
- Instruments
- Software & Services
- Quantitative
- Italy Real time PCR, digital PCR, and end-point PCRMarket, By Application, 2018 - 2030 (USD Million)
- Clinical
- Pathogen Testing
- Oncology testing
- Blood Screening
- Liquid Biopsy
- dPCR-based Non-Invasive Prenatal Testing (NIPT)
- Others
- Research
- Stem Cell Research
- DNA Cloning & Sequencing
- Recombinant DNA Technology
- Rare Mutation Detection
- Gene Expression
- Single Cell Analysis
- Microbiome Analysis
- Copy Number Variation Analysis
- Library Quantification (NGS)
- Characterization of Low-fold Changes in mRNA and miRNA
- Expression"
- Species Identification
- GMO Detection
- Others
- Forensic
- Clinical
- Italy Real time PCR, digital PCR, and end-point PCRMarket, by Product 2018 - 2030 (USD Million)
- Consumables & Reagents
- Instruments
- Software & Services
- Italy Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Spain
- Spain Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Quantitative
- Consumables & Reagents
- Instruments
- Software & Services
- Digital
- Consumables & Reagents
- Instruments
- Software & Services
- End-point
- Consumables & Reagents
- Instruments
- Software & Services
- Quantitative
- Spain Real time PCR, digital PCR, and end-point PCRMarket, By Application, 2018 - 2030 (USD Million)
- Clinical
- Pathogen Testing
- Oncology testing
- Blood Screening
- Liquid Biopsy
- dPCR-based Non-Invasive Prenatal Testing (NIPT)
- Others
- Research
- Stem Cell Research
- DNA Cloning & Sequencing
- Recombinant DNA Technology
- Rare Mutation Detection
- Gene Expression
- Single Cell Analysis
- Microbiome Analysis
- Copy Number Variation Analysis
- Library Quantification (NGS)
- Characterization of Low-fold Changes in mRNA and miRNA
- Expression"
- Species Identification
- GMO Detection
- Others
- Forensic
- Clinical
- Spain Real time PCR, digital PCR, and end-point PCRMarket, by Product 2018 - 2030 (USD Million)
- Consumables & Reagents
- Instruments
- Software & Services
- Spain Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Denmark
- Denmark Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Quantitative
- Consumables & Reagents
- Instruments
- Software & Services
- Digital
- Consumables & Reagents
- Instruments
- Software & Services
- End-point
- Consumables & Reagents
- Instruments
- Software & Services
- Quantitative
- Denmark Real time PCR, digital PCR, and end-point PCRMarket, By Application, 2018 - 2030 (USD Million)
- Clinical
- Pathogen Testing
- Oncology testing
- Blood Screening
- Liquid Biopsy
- dPCR-based Non-Invasive Prenatal Testing (NIPT)
- Others
- Research
- Stem Cell Research
- DNA Cloning & Sequencing
- Recombinant DNA Technology
- Rare Mutation Detection
- Gene Expression
- Single Cell Analysis
- Microbiome Analysis
- Copy Number Variation Analysis
- Library Quantification (NGS)
- Characterization of Low-fold Changes in mRNA and miRNA
- Expression"
- Species Identification
- GMO Detection
- Others
- Forensic
- Clinical
- Denmark Real time PCR, digital PCR, and end-point PCRMarket, by Product 2018 - 2030 (USD Million)
- Consumables & Reagents
- Instruments
- Software & Services
- Denmark Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Sweden
- Sweden Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Quantitative
- Consumables & Reagents
- Instruments
- Software & Services
- Digital
- Consumables & Reagents
- Instruments
- Software & Services
- End-point
- Consumables & Reagents
- Instruments
- Software & Services
- Quantitative
- Sweden Real time PCR, digital PCR, and end-point PCRMarket, By Application, 2018 - 2030 (USD Million)
- Clinical
- Pathogen Testing
- Oncology testing
- Blood Screening
- Liquid Biopsy
- dPCR-based Non-Invasive Prenatal Testing (NIPT)
- Others
- Research
- Stem Cell Research
- DNA Cloning & Sequencing
- Recombinant DNA Technology
- Rare Mutation Detection
- Gene Expression
- Single Cell Analysis
- Microbiome Analysis
- Copy Number Variation Analysis
- Library Quantification (NGS)
- Characterization of Low-fold Changes in mRNA and miRNA
- Expression"
- Species Identification
- GMO Detection
- Others
- Forensic
- Clinical
- Sweden Real time PCR, digital PCR, and end-point PCRMarket, by Product 2018 - 2030 (USD Million)
- Consumables & Reagents
- Instruments
- Software & Services
- Sweden Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Norway
- Norway Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Quantitative
- Consumables & Reagents
- Instruments
- Software & Services
- Digital
- Consumables & Reagents
- Instruments
- Software & Services
- End-point
- Consumables & Reagents
- Instruments
- Software & Services
- Quantitative
- Norway Real time PCR, digital PCR, and end-point PCRMarket, By Application, 2018 - 2030 (USD Million)
- Clinical
- Pathogen Testing
- Oncology testing
- Blood Screening
- Liquid Biopsy
- dPCR-based Non-Invasive Prenatal Testing (NIPT)
- Others
- Research
- Stem Cell Research
- DNA Cloning & Sequencing
- Recombinant DNA Technology
- Rare Mutation Detection
- Gene Expression
- Single Cell Analysis
- Microbiome Analysis
- Copy Number Variation Analysis
- Library Quantification (NGS)
- Characterization of Low-fold Changes in mRNA and miRNA
- Expression"
- Species Identification
- GMO Detection
- Others
- Forensic
- Clinical
- Norway Real time PCR, digital PCR, and end-point PCRMarket, by Product 2018 - 2030 (USD Million)
- Consumables & Reagents
- Instruments
- Software & Services
- Norway Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Europe Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Asia Pacific
- Asia Pacific Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Quantitative
- Consumables & Reagents
- Instruments
- Software & Services
- Digital
- Consumables & Reagents
- Instruments
- Software & Services
- End-point
- Consumables & Reagents
- Instruments
- Software & Services
- Quantitative
- Asia Pacific Real time PCR, digital PCR, and end-point PCRMarket, By Application, 2018 - 2030 (USD Million)
- Clinical
- Pathogen Testing
- Oncology testing
- Blood Screening
- Liquid Biopsy
- dPCR-based Non-Invasive Prenatal Testing (NIPT)
- Others
- Research
- Stem Cell Research
- DNA Cloning & Sequencing
- Recombinant DNA Technology
- Rare Mutation Detection
- Gene Expression
- Single Cell Analysis
- Microbiome Analysis
- Copy Number Variation Analysis
- Library Quantification (NGS)
- Characterization of Low-fold Changes in mRNA and miRNA
- Expression"
- Species Identification
- GMO Detection
- Others
- Forensic
- Clinical
- Asia Pacific Real time PCR, digital PCR, and end-point PCRMarket, by Product 2018 - 2030 (USD Million)
- Consumables & Reagents
- Instruments
- Software & Services
- Japan
- Japan Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Quantitative
- Consumables & Reagents
- Instruments
- Software & Services
- Digital
- Consumables & Reagents
- Instruments
- Software & Services
- End-point
- Consumables & Reagents
- Instruments
- Software & Services
- Quantitative
- Japan Real time PCR, digital PCR, and end-point PCRMarket, By Application, 2018 - 2030 (USD Million)
- Clinical
- Pathogen Testing
- Oncology testing
- Blood Screening
- Liquid Biopsy
- dPCR-based Non-Invasive Prenatal Testing (NIPT)
- Others
- Research
- Stem Cell Research
- DNA Cloning & Sequencing
- Recombinant DNA Technology
- Rare Mutation Detection
- Gene Expression
- Single Cell Analysis
- Microbiome Analysis
- Copy Number Variation Analysis
- Library Quantification (NGS)
- Characterization of Low-fold Changes in mRNA and miRNA
- Expression"
- Species Identification
- GMO Detection
- Others
- Forensic
- Clinical
- Japan Real time PCR, digital PCR, and end-point PCRMarket, by Product 2018 - 2030 (USD Million)
- Consumables & Reagents
- Instruments
- Software & Services
- China
- China Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Quantitative
- Consumables & Reagents
- Instruments
- Software & Services
- Digital
- Consumables & Reagents
- Instruments
- Software & Services
- End-point
- Consumables & Reagents
- Instruments
- Software & Services
- Quantitative
- China Real time PCR, digital PCR, and end-point PCRMarket, By Application, 2018 - 2030 (USD Million)
- Clinical
- Pathogen Testing
- Oncology testing
- Blood Screening
- Liquid Biopsy
- dPCR-based Non-Invasive Prenatal Testing (NIPT)
- Others
- Research
- Stem Cell Research
- DNA Cloning & Sequencing
- Recombinant DNA Technology
- Rare Mutation Detection
- Gene Expression
- Single Cell Analysis
- Microbiome Analysis
- Copy Number Variation Analysis
- Library Quantification (NGS)
- Characterization of Low-fold Changes in mRNA and miRNA
- Expression"
- Species Identification
- GMO Detection
- Others
- Forensic
- Clinical
- China Real time PCR, digital PCR, and end-point PCRMarket, by Product 2018 - 2030 (USD Million)
- Consumables & Reagents
- Instruments
- Software & Services
- China Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- India
- India Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Quantitative
- Consumables & Reagents
- Instruments
- Software & Services
- Digital
- Consumables & Reagents
- Instruments
- Software & Services
- End-point
- Consumables & Reagents
- Instruments
- Software & Services
- Quantitative
- India Real time PCR, digital PCR, and end-point PCRMarket, By Application, 2018 - 2030 (USD Million)
- Clinical
- Pathogen Testing
- Oncology testing
- Blood Screening
- Liquid Biopsy
- dPCR-based Non-Invasive Prenatal Testing (NIPT)
- Others
- Research
- Stem Cell Research
- DNA Cloning & Sequencing
- Recombinant DNA Technology
- Rare Mutation Detection
- Gene Expression
- Single Cell Analysis
- Microbiome Analysis
- Copy Number Variation Analysis
- Library Quantification (NGS)
- Characterization of Low-fold Changes in mRNA and miRNA
- Expression"
- Species Identification
- GMO Detection
- Others
- Forensic
- Clinical
- India Real time PCR, digital PCR, and end-point PCRMarket, by Product 2018 - 2030 (USD Million)
- Consumables & Reagents
- Instruments
- Software & Services
- India Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Australia
- Australia Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Quantitative
- Consumables & Reagents
- Instruments
- Software & Services
- Digital
- Consumables & Reagents
- Instruments
- Software & Services
- End-point
- Consumables & Reagents
- Instruments
- Software & Services
- Quantitative
- Australia Real time PCR, digital PCR, and end-point PCRMarket, By Application, 2018 - 2030 (USD Million)
- Clinical
- Pathogen Testing
- Oncology testing
- Blood Screening
- Liquid Biopsy
- dPCR-based Non-Invasive Prenatal Testing (NIPT)
- Others
- Research
- Stem Cell Research
- DNA Cloning & Sequencing
- Recombinant DNA Technology
- Rare Mutation Detection
- Gene Expression
- Single Cell Analysis
- Microbiome Analysis
- Copy Number Variation Analysis
- Library Quantification (NGS)
- Characterization of Low-fold Changes in mRNA and miRNA
- Expression"
- Species Identification
- GMO Detection
- Others
- Forensic
- Clinical
- Australia Real time PCR, digital PCR, and end-point PCRMarket, by Product 2018 - 2030 (USD Million)
- Consumables & Reagents
- Instruments
- Software & Services
- Australia Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- South Korea
- South Korea Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Quantitative
- Consumables & Reagents
- Instruments
- Software & Services
- Digital
- Consumables & Reagents
- Instruments
- Software & Services
- End-point
- Consumables & Reagents
- Instruments
- Software & Services
- Quantitative
- South Korea Real time PCR, digital PCR, and end-point PCRMarket, By Application, 2018 - 2030 (USD Million)
- Clinical
- Pathogen Testing
- Oncology testing
- Blood Screening
- Liquid Biopsy
- dPCR-based Non-Invasive Prenatal Testing (NIPT)
- Others
- Research
- Stem Cell Research
- DNA Cloning & Sequencing
- Recombinant DNA Technology
- Rare Mutation Detection
- Gene Expression
- Single Cell Analysis
- Microbiome Analysis
- Copy Number Variation Analysis
- Library Quantification (NGS)
- Characterization of Low-fold Changes in mRNA and miRNA
- Expression"
- Species Identification
- GMO Detection
- Others
- Forensic
- Clinical
- South Korea Real time PCR, digital PCR, and end-point PCRMarket, by Product 2018 - 2030 (USD Million)
- Consumables & Reagents
- Instruments
- Software & Services
- South Korea Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Thailand
- Thailand Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Quantitative
- Consumables & Reagents
- Instruments
- Software & Services
- Digital
- Consumables & Reagents
- Instruments
- Software & Services
- End-point
- Consumables & Reagents
- Instruments
- Software & Services
- Quantitative
- Thailand Real time PCR, digital PCR, and end-point PCRMarket, By Application, 2018 - 2030 (USD Million)
- Clinical
- Pathogen Testing
- Oncology testing
- Blood Screening
- Liquid Biopsy
- dPCR-based Non-Invasive Prenatal Testing (NIPT)
- Others
- Research
- Stem Cell Research
- DNA Cloning & Sequencing
- Recombinant DNA Technology
- Rare Mutation Detection
- Gene Expression
- Single Cell Analysis
- Microbiome Analysis
- Copy Number Variation Analysis
- Library Quantification (NGS)
- Characterization of Low-fold Changes in mRNA and miRNA
- Expression"
- Species Identification
- GMO Detection
- Others
- Forensic
- Clinical
- Thailand Real time PCR, digital PCR, and end-point PCRMarket, by Product 2018 - 2030 (USD Million)
- Consumables & Reagents
- Instruments
- Software & Services
- Thailand Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Japan Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Latin America
- Latin America Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Quantitative
- Consumables & Reagents
- Instruments
- Software & Services
- Digital
- Consumables & Reagents
- Instruments
- Software & Services
- End-point
- Consumables & Reagents
- Instruments
- Software & Services
- Quantitative
- Latin America Real time PCR, digital PCR, and end-point PCRMarket, By Application, 2018 - 2030 (USD Million)
- Clinical
- Pathogen Testing
- Oncology testing
- Blood Screening
- Liquid Biopsy
- dPCR-based Non-Invasive Prenatal Testing (NIPT)
- Others
- Research
- Stem Cell Research
- DNA Cloning & Sequencing
- Recombinant DNA Technology
- Rare Mutation Detection
- Gene Expression
- Single Cell Analysis
- Microbiome Analysis
- Copy Number Variation Analysis
- Library Quantification (NGS)
- Characterization of Low-fold Changes in mRNA and miRNA
- Expression"
- Species Identification
- GMO Detection
- Others
- Forensic
- Clinical
- Latin America Real time PCR, digital PCR, and end-point PCRMarket, by Product 2018 - 2030 (USD Million)
- Consumables & Reagents
- Instruments
- Software & Services
- Brazil
- Brazil Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Quantitative
- Consumables & Reagents
- Instruments
- Software & Services
- Digital
- Consumables & Reagents
- Instruments
- Software & Services
- End-point
- Consumables & Reagents
- Instruments
- Software & Services
- Quantitative
- Brazil Real time PCR, digital PCR, and end-point PCRMarket, By Application, 2018 - 2030 (USD Million)
- Clinical
- Pathogen Testing
- Oncology testing
- Blood Screening
- Liquid Biopsy
- dPCR-based Non-Invasive Prenatal Testing (NIPT)
- Others
- Research
- Stem Cell Research
- DNA Cloning & Sequencing
- Recombinant DNA Technology
- Rare Mutation Detection
- Gene Expression
- Single Cell Analysis
- Microbiome Analysis
- Copy Number Variation Analysis
- Library Quantification (NGS)
- Characterization of Low-fold Changes in mRNA and miRNA
- Expression"
- Species Identification
- GMO Detection
- Others
- Forensic
- Clinical
- Brazil Real time PCR, digital PCR, and end-point PCRMarket, by Product 2018 - 2030 (USD Million)
- Consumables & Reagents
- Instruments
- Software & Services
- Brazil Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Mexico
- Mexico Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Quantitative
- Consumables & Reagents
- Instruments
- Software & Services
- Digital
- Consumables & Reagents
- Instruments
- Software & Services
- End-point
- Consumables & Reagents
- Instruments
- Software & Services
- Quantitative
- Mexico Real time PCR, digital PCR, and end-point PCRMarket, By Application, 2018 - 2030 (USD Million)
- Clinical
- Pathogen Testing
- Oncology testing
- Blood Screening
- Liquid Biopsy
- dPCR-based Non-Invasive Prenatal Testing (NIPT)
- Others
- Research
- Stem Cell Research
- DNA Cloning & Sequencing
- Recombinant DNA Technology
- Rare Mutation Detection
- Gene Expression
- Single Cell Analysis
- Microbiome Analysis
- Copy Number Variation Analysis
- Library Quantification (NGS)
- Characterization of Low-fold Changes in mRNA and miRNA
- Expression"
- Species Identification
- GMO Detection
- Others
- Forensic
- Clinical
- Mexico Real time PCR, digital PCR, and end-point PCRMarket, by Product 2018 - 2030 (USD Million)
- Consumables & Reagents
- Instruments
- Software & Services
- Mexico Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Argentina
- Argentina Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Quantitative
- Consumables & Reagents
- Instruments
- Software & Services
- Digital
- Consumables & Reagents
- Instruments
- Software & Services
- End-point
- Consumables & Reagents
- Instruments
- Software & Services
- Quantitative
- Argentina Real time PCR, digital PCR, and end-point PCRMarket, By Application, 2018 - 2030 (USD Million)
- Clinical
- Pathogen Testing
- Oncology testing
- Blood Screening
- Liquid Biopsy
- dPCR-based Non-Invasive Prenatal Testing (NIPT)
- Others
- Research
- Stem Cell Research
- DNA Cloning & Sequencing
- Recombinant DNA Technology
- Rare Mutation Detection
- Gene Expression
- Single Cell Analysis
- Microbiome Analysis
- Copy Number Variation Analysis
- Library Quantification (NGS)
- Characterization of Low-fold Changes in mRNA and miRNA
- Expression"
- Species Identification
- GMO Detection
- Others
- Forensic
- Clinical
- Argentina Real time PCR, digital PCR, and end-point PCRMarket, by Product 2018 - 2030 (USD Million)
- Consumables & Reagents
- Instruments
- Software & Services
- Argentina Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Latin America Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Middle East & Africa
- Middle East & Africa Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Quantitative
- Consumables & Reagents
- Instruments
- Software & Services
- Digital
- Consumables & Reagents
- Instruments
- Software & Services
- End-point
- Consumables & Reagents
- Instruments
- Software & Services
- Quantitative
- Middle East & Africa Real time PCR, digital PCR, and end-point PCRMarket, By Application, 2018 - 2030 (USD Million)
- Clinical
- Pathogen Testing
- Oncology testing
- Blood Screening
- Liquid Biopsy
- dPCR-based Non-Invasive Prenatal Testing (NIPT)
- Others
- Research
- Stem Cell Research
- DNA Cloning & Sequencing
- Recombinant DNA Technology
- Rare Mutation Detection
- Gene Expression
- Single Cell Analysis
- Microbiome Analysis
- Copy Number Variation Analysis
- Library Quantification (NGS)
- Characterization of Low-fold Changes in mRNA and miRNA
- Expression"
- Species Identification
- GMO Detection
- Others
- Forensic
- Clinical
- Middle East & Africa Real time PCR, digital PCR, and end-point PCRMarket, by Product 2018 - 2030 (USD Million)
- Consumables & Reagents
- Instruments
- Software & Services
- South Africa
- South Africa Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Quantitative
- Consumables & Reagents
- Instruments
- Software & Services
- Digital
- Consumables & Reagents
- Instruments
- Software & Services
- End-point
- Consumables & Reagents
- Instruments
- Software & Services
- Quantitative
- South Africa Real time PCR, digital PCR, and end-point PCRMarket, By Application, 2018 - 2030 (USD Million)
- Clinical
- Pathogen Testing
- Oncology testing
- Blood Screening
- Liquid Biopsy
- dPCR-based Non-Invasive Prenatal Testing (NIPT)
- Others
- Research
- Stem Cell Research
- DNA Cloning & Sequencing
- Recombinant DNA Technology
- Rare Mutation Detection
- Gene Expression
- Single Cell Analysis
- Microbiome Analysis
- Copy Number Variation Analysis
- Library Quantification (NGS)
- Characterization of Low-fold Changes in mRNA and miRNA
- Expression"
- Species Identification
- GMO Detection
- Others
- Forensic
- Clinical
- South Africa Real time PCR, digital PCR, and end-point PCRMarket, by Product 2018 - 2030 (USD Million)
- Consumables & Reagents
- Instruments
- Software & Services
- South Africa Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Saudi Arabia
- Saudi Arabia Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Quantitative
- Consumables & Reagents
- Instruments
- Software & Services
- Digital
- Consumables & Reagents
- Instruments
- Software & Services
- End-point
- Consumables & Reagents
- Instruments
- Software & Services
- Quantitative
- Saudi Arabia Real time PCR, digital PCR, and end-point PCRMarket, By Application, 2018 - 2030 (USD Million)
- Clinical
- Pathogen Testing
- Oncology testing
- Blood Screening
- Liquid Biopsy
- dPCR-based Non-Invasive Prenatal Testing (NIPT)
- Others
- Research
- Stem Cell Research
- DNA Cloning & Sequencing
- Recombinant DNA Technology
- Rare Mutation Detection
- Gene Expression
- Single Cell Analysis
- Microbiome Analysis
- Copy Number Variation Analysis
- Library Quantification (NGS)
- Characterization of Low-fold Changes in mRNA and miRNA
- Expression"
- Species Identification
- GMO Detection
- Others
- Forensic
- Clinical
- Saudi Arabia Real time PCR, digital PCR, and end-point PCRMarket, by Product 2018 - 2030 (USD Million)
- Consumables & Reagents
- Instruments
- Software & Services
- Saudi Arabia Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- UAE
- UAE Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Quantitative
- Consumables & Reagents
- Instruments
- Software & Services
- Digital
- Consumables & Reagents
- Instruments
- Software & Services
- End-point
- Consumables & Reagents
- Instruments
- Software & Services
- Quantitative
- UAE Real time PCR, digital PCR, and end-point PCRMarket, By Application, 2018 - 2030 (USD Million)
- Clinical
- Pathogen Testing
- Oncology testing
- Blood Screening
- Liquid Biopsy
- dPCR-based Non-Invasive Prenatal Testing (NIPT)
- Others
- Research
- Stem Cell Research
- DNA Cloning & Sequencing
- Recombinant DNA Technology
- Rare Mutation Detection
- Gene Expression
- Single Cell Analysis
- Microbiome Analysis
- Copy Number Variation Analysis
- Library Quantification (NGS)
- Characterization of Low-fold Changes in mRNA and miRNA
- Expression"
- Species Identification
- GMO Detection
- Others
- Forensic
- Clinical
- UAE Real time PCR, digital PCR, and end-point PCRMarket, by Product 2018 - 2030 (USD Million)
- Consumables & Reagents
- Instruments
- Software & Services
- UAE Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Kuwait
- Kuwait Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Quantitative
- Consumables & Reagents
- Instruments
- Software & Services
- Digital
- Consumables & Reagents
- Instruments
- Software & Services
- End-point
- Consumables & Reagents
- Instruments
- Software & Services
- Quantitative
- Kuwait Real time PCR, digital PCR, and end-point PCRMarket, By Application, 2018 - 2030 (USD Million)
- Clinical
- Pathogen Testing
- Oncology testing
- Blood Screening
- Liquid Biopsy
- dPCR-based Non-Invasive Prenatal Testing (NIPT)
- Others
- Research
- Stem Cell Research
- DNA Cloning & Sequencing
- Recombinant DNA Technology
- Rare Mutation Detection
- Gene Expression
- Single Cell Analysis
- Microbiome Analysis
- Copy Number Variation Analysis
- Library Quantification (NGS)
- Characterization of Low-fold Changes in mRNA and miRNA
- Expression"
- Species Identification
- GMO Detection
- Others
- Forensic
- Clinical
- Kuwait Real time PCR, digital PCR, and end-point PCRMarket, by Product 2018 - 2030 (USD Million)
- Consumables & Reagents
- Instruments
- Software & Services
- Kuwait Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- Middle East & Africa Real time PCR, digital PCR, and end-point PCRMarket, By Technology 2018 - 2030 (USD Million)
- North America
Real-time PCR, Digital PCR, And End-point PCR Market Dynamics
Driver: Rising Incidence of Chronic Diseases, Infectious Diseases, And Genetic Disorders
The increasing prevalence of chronic & infectious diseases and genetic disorders, such as Alzheimer’s disease, Turner syndrome, & Parkinson’s disease, is expected to boost the market demand during the forecast period. According to the CDC, chronic diseases, such as cancer, diabetes, & chronic kidney diseases, and respiratory diseases including asthma, are accountable for 7 in 10 deaths in the U.S. each year. Moreover, 6 out of 10 adults suffer from a chronic disease in the U.S. These chronic diseases are accountable for USD 3.5 trillion in healthcare costs in the U.S. annually. In addition, the Hepatitis B Foundation estimated that nearly 2 billion people were infected with hepatitis B infection in 2016. A recent study published by the NCBI states that as of 2018, 292 million people globally were infected chronically by hepatitis B. Moreover, 780,000 deaths occur due to hepatitis B annually. Rapid detection of infectious diseases with the use of PCR facilitates timely intervention and appropriate treatment. For instance, the detection of tuberculosis is slow through conventional techniques, which can be overcome with the use of PCR for faster results.
Driver: Technological Advancements in PCR
Over the recent years, PCR has witnessed technological advancements in terms of sensitivity, accuracy, efficiency, and cost-effectiveness. Key market players are introducing novel technologies to maintain a competitive edge. A growing number of automated instruments and their easy availability are among the factors expected to drive market growth. In addition, improvements in technology and the consequent introduction of affordable & high-efficacy products in the market are expected to drive the market. qPCR offers several benefits over traditional methods of PCR, such as automation, precision, detection of small pathogens, and reduction in errors. dPCR has a high-throughput system that reduces the time required for obtaining results. It also requires a relatively low amount of sample and provides higher accuracy, thereby creating a huge demand for these systems. Key players operating in the market are focusing on introducing novel & technologically advanced devices for PCR tests. For instance, in July 2017, Bio-Rad Laboratories launched droplet digital PCR Genome Edit Detection Assays to quantify the efficiency of CRISPR-Cas9 or any other genome using the technology of Bio-Rad’s droplet digital PCR.
Restraint: High Device Costs Associated with Real-Time PCR (QPCR)
The current cost associated with Real-time PCR (qPCR) devices is on the higher side. The cost of the CFX Connect PCR Detection System by Bio-Rad Laboratories is approximately USD 17,995, whereas the cost of Thermo Fisher Scientific’s 7900 HT qPCR system ranges from USD 20,000 to USD 30,000. Digital PCR instruments with more accurate results and sensitivity cost more than real-time PCR instruments. A manual dPCR costs between USD 65,000 and USD 70,000, whereas an automated dPCR costs USD 100,000. Thermo Fisher Scientific’s Open Array Real-Time PCR System (with TaqMan OpenArray Digital PCR Plates) costs USD 140,000 for the complete system and Bio-Rad Laboratories QX100 ddPCR system costs USD 89,000. The high cost of qPCR devices is expected to restrain the market growth.
What Does This Report Include?
This section will provide insights into the contents included in this real-time pcr, digital pcr, and end-point pcr market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.
Real-time pcr, digital pcr, and end-point pcr market qualitative analysis
-
Industry overview
-
Industry trends
-
Market drivers and restraints
-
Market size
-
Growth prospects
-
Porter’s analysis
-
PESTEL analysis
-
Key market opportunities prioritized
-
Competitive landscape
-
Company overview
-
Financial performance
-
Product benchmarking
-
Latest strategic developments
-
Real-time pcr, digital pcr, and end-point pcr market quantitative analysis
-
Market size, estimates, and forecast from 2018 to 2030
-
Market estimates and forecast for product segments up to 2030
-
Regional market size and forecast for product segments up to 2030
-
Market estimates and forecast for application segments up to 2030
-
Regional market size and forecast for application segments up to 2030
-
Company financial performance
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
